News & Events

The project aims at Quantitative Systems Pharmacology modeling of a T-cell engager to identify first-in-human dose and predict optimal step-up dosing regimen

InSysBio, one of the world's pioneers of Quantitative Systems Pharmacology (QSP) modeling, announces the extension of collaboration with BeOne Medicines, a global oncology company.

The project aims at mechanistic PK/RO modeling to predict optimal dose and regimen of BGB-B2033, GPC3 x 4-1BB bispecific antibody

InSysBio, one of the world's pioneers of Quantitative Systems Pharmacology (QSP) modeling, announces its collaboration with BeOne Medicines, a global oncology company.

InSysBio launches a new data annotation service designed to support researchers and analysts who require specific, literature-based biological data to be added to InSysBio’s CYTOCON or fIVE databases for use in QSP modeling, analysis, or decision-making. The new service allows clients to submit targeted data requests related to diseases, tissues, cell types, and cytokines

InSysBio announces their participation in BioTechX Europe 2025. Oleg Demin, Chief Scientific Advisor and co-founder of InSysBio, and Igor Goryanin, Professor at University of Edinburgh, will host a roundtable discussion entitled, "Integrating Artificial Intelligence with Quantitative Systems Pharmacology (QSP): Opportunities and Challenges"

InSysBio announces its participation in JuliaCon Local Paris 2025 which is to be held from October 2-3, 2025 at the National Conservatory of Arts and Crafts, Paris, France. Ivan Borisov, Senior Software Developer at InSysBio, will present a poster in frames of the Conference

InSysBio announces its participation in BioTechX Europe 2025 on 6–8 October 2025 at Messe Basel, Switzerland. Oleg Demin, Chief Scientific Advisor and co-founder of InSysBio, is going to present InSysBio's modeling services for drug research & development at the Booth S62